Crestor Generics On Hold As FDA, AstraZeneca Talk About Exclusivity
This article was originally published in The Pink Sheet Daily
Executive Summary
Court postpones a decision on a temporary restraining order and asks parties to reach agreement on how FDA is to proceed with pending ANDAs.